DaRe2THINK

News

A new digital platform designed to make it easier for GPs in the NHS to participate in clinical trials has been formally launched in the UK.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.